You are here: Industry Insights > COVID-19

News List

Health Canada approves J&J Covid-19 vaccine for use in adults Pharmaceutical-Technology
November 26, 2021
Health Canada has granted full approval for Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine for active immunisation to prevent infection in adults aged 18 years and older.
GreenLight and Samsung Biologics to produce Covid-19 vaccines Pharmaceutical-Technology
November 26, 2021
GreenLight Biosciences and Samsung Biologics have signed a collaboration agreement for manufacturing messenger ribonucleic acid (mRNA) Covid-19 vaccines.
Next phase of Hawaii state and county COVID-19 measures announced prnewswire
November 25, 2021
Gov. David Ige and the county mayors today announced the next phase of state and county measures related to COVID-19.
Pfizer, BioNTech Booster Gets EUA in 18 and Older ContractPharma
November 25, 2021
The U.S. FDA has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years and older.
Delta Featured Its New Delta U+ Far-UVC Light Care 222(R) Series at Industrial Transformation ASIA-PACIFIC (ITAP) 2021 prnasia
November 25, 2021
Delta Electronics Int'l (Singapore), a provider of power and thermal management solutions, featured a range of solutions at the fourth edition of the Industrial Transformation ASIA-PACIFIC (ITAP) on 22 to 24 November 2021.
Covaxin shows 50 per cent effectiveness against symptomatic COVID in real-world assessment: Lancet study ExpressPharma
November 25, 2021
Two doses of Covaxin are 50 per cent effective against symptomatic COVID-19, according to the first real-world assessment of India’s indigenous coronavirus vaccine published in The Lancet Infectious Diseases journal.
EU considers vaccine boosters for all adults ExpressPharma
November 25, 2021
The head of the European Union’s public health agency Andrea Ammon said yesterday that COVID-19 vaccine boosters should be considered for all adults, with priority for those above 40 years...
Seqirus Announces U.S. FDA Approval for Multi-Dose Vial Presentation of First-Ever Adjuvanted, Cell-Based Pandemic Influenza Vaccine prnewswire
November 25, 2021
iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it has been contracted to support new advanced research on COVID-19...
Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore prnewswire
November 25, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced its submission...
Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older AmericanPharmaceuticalReview
November 25, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that Health Canada has approved its single-shot COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page